Elena V. Ivanova

15.8k total citations · 2 hit papers
80 papers, 4.7k citations indexed

About

Elena V. Ivanova is a scholar working on Molecular Biology, Oncology and Genetics. According to data from OpenAlex, Elena V. Ivanova has authored 80 papers receiving a total of 4.7k indexed citations (citations by other indexed papers that have themselves been cited), including 44 papers in Molecular Biology, 27 papers in Oncology and 18 papers in Genetics. Recurrent topics in Elena V. Ivanova's work include Epigenetics and DNA Methylation (14 papers), Genetic Syndromes and Imprinting (9 papers) and PI3K/AKT/mTOR signaling in cancer (6 papers). Elena V. Ivanova is often cited by papers focused on Epigenetics and DNA Methylation (14 papers), Genetic Syndromes and Imprinting (9 papers) and PI3K/AKT/mTOR signaling in cancer (6 papers). Elena V. Ivanova collaborates with scholars based in United States, United Kingdom and Spain. Elena V. Ivanova's co-authors include David Pellman, Alexei Protopopov, Roderick T. Bronson, Madhavi Bandi, Takeshi Fujiwara, Masayuki Nitta, Karen Crasta, Alexandra B. Lantermann, Neil J. Ganem and Dipanjan Chowdhury and has published in prestigious journals such as Nature, Cell and Nucleic Acids Research.

In The Last Decade

Elena V. Ivanova

75 papers receiving 4.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

DNA breaks and chromosome pulverization from errors in mitosis

2012 902 citations Elena V. Ivanova, Alexei Protopopov et al. Nature profile →
Cytokinesis failure generating tetraploids promotes tumorigenesis in p53-null cells

2005 825 citations Elena V. Ivanova et al. Nature profile →

Peers

Countries citing papers authored by Elena V. Ivanova

Since Specialization

Citations

This map shows the geographic impact of Elena V. Ivanova's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elena V. Ivanova with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elena V. Ivanova more than expected).

Fields of papers citing papers by Elena V. Ivanova

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elena V. Ivanova. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elena V. Ivanova. The network helps show where Elena V. Ivanova may publish in the future.

Co-authorship network of co-authors of Elena V. Ivanova

This figure shows the co-authorship network connecting the top 25 collaborators of Elena V. Ivanova. A scholar is included among the top collaborators of Elena V. Ivanova based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elena V. Ivanova. Elena V. Ivanova is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Phase I Clinical Trial of the Bifunctional EGFR/TGF-β Fusion Protein Ficerafusp Alfa (BCA101) Alone and in Combination with Pembrolizumab for Advanced Solid Tumors 2025 ·Clinical Cancer Research ·(unknown), Richard D. Carvajal, Paul K. Paik, Van K. Morris, Dan P. Zandberg, John M. Kaczmar, (unknown), (unknown), (unknown), (unknown), Patrick H. Lizotte, Elena V. Ivanova, Philippe L. Bédard, Glenn J. Hanna	0
2	Roles and Regulation of DNA Methylation in Early Mammalian Development 2025 ·Annual Review of Animal Biosciences ·Elena V. Ivanova, Gavin Kelsey	0
3	442 CAIX targeted CAR-T cells exhibited antitumor efficacy on renal cell carcinoma (RCC) patient derived organotypic tumor spheroids (PDOTS) 2023 ·SHILAP Revista de lepidopterología ·Yufei Wang, Alicia Buck, Brandon Piel, (unknown), (unknown), Kun Huang, (unknown), Marion Grimaud, (unknown), Miriam Ficial, Sabina Signoretti, Tran C. Thai, Elena V. Ivanova, Cloud P. Paweletz, Ming-Ru Wu, Jon O. Wee, Toni K. Choueiri, Gordon J. Freeman, David A. Barbie, Wayne A. Marasco	1
4	Sensitivity to targeted UBA1 inhibition in a myeloid cell line model of VEXAS syndrome 2023 ·Blood Advances ·(unknown), (unknown), (unknown), Maria Ericsson, (unknown), Elena V. Ivanova, Gabriel K. Griffin, Dilshad H. Khan, Roger Belizaire	10
5	Cotargeting a MYC/eIF4A-survival axis improves the efficacy of KRAS inhibitors in lung cancer 2023 ·Journal of Clinical Investigation ·Francesca Nardi, Naiara Perurena, Amy E. Schade, Zehua Li, Kenneth Ngo, Elena V. Ivanova, (unknown), Chendi Li, Prafulla C. Gokhale, Aaron N. Hata, David A. Barbie, Cloud P. Paweletz, Pasi A. Jänne, Karen Cichowski	12
6	Embryonic Stem Cell-Derived Neurons as a Model System for Epigenome Maturation during Development 2023 ·Genes ·Sally Martin, Daniel Poppe, Nelly Olova, Conor O’Leary, Elena V. Ivanova, Jahnvi Pflueger, (unknown), Rebecca K. Simmons, Helen Cooper, Wolf Reik, Ryan Lister, Ernst J. Wolvetang	3
7	Effect of Superovulation Treatment on Oocyte’s DNA Methylation 2022 ·International Journal of Molecular Sciences ·(unknown), Elena V. Ivanova, S. Ruíz, Simon Andrews, Gavin Kelsey, Pilar Coy	8
8	MA12.06 Patient-Derived Organotypic Tumor Spheroids (PDOTS) Facilitate Therapeutic Screening for Malignant Pleural Mesothelioma 2019 ·Journal of Thoracic Oncology ·Dalia Larios, Elena V. Ivanova, Ahmed Aref, Andrew Portell, Assunta De Rienzo, David A. Barbie, Cloud P. Paweletz, Raphael Bueno	1
9	Suppression of STING Associated with LKB1 Loss in KRAS-Driven Lung Cancer 2018 ·Cancer Discovery ·Shunsuke Kitajima, Elena V. Ivanova, Sujuan Guo, Ryohei Yoshida, Marco Campisi, Shriram K. Sundararaman, Shoichiro Tange, Yoichiro Mitsuishi, Tran C. Thai, Sayuri Masuda, Brandon Piel, Lynette M. Sholl, Paul T. Kirschmeier, Cloud P. Paweletz, Hideo Watanabe, Mamiko Yajima, David A. Barbie	348
10	TRIM13 (RFP2) downregulation decreases tumour cell growth in multiple myeloma through inhibition of NF Kappa B pathway and proteasome activity 2013 ·British Journal of Haematology ·Moshe E. Gatt, Kohichi Takada, Mala Mani, Mikael Lerner, Marjorie Pick, Teru Hideshima, Daniel E. Carrasco, Alexei Protopopov, Elena V. Ivanova, Olle Sangfelt, Dan Grandér, Bart Barlogie, John D. Shaughnessy, Kenneth C. Anderson, Daniel R. Carrasco	24
11	Exposure to the Saturated Free Fatty Acid Palmitate Alters BV-2 Microglia Inflammatory Response 2013 ·Journal of Molecular Neuroscience ·(unknown), Filip Bergqvist, Elena V. Ivanova, Kristin Jacobsen, Kerstin Iverfeldt	42
12	DNA methylation at differentially methylated regions of imprinted genes is resistant to developmental programming by maternal nutrition 2012 ·Epigenetics ·Elena V. Ivanova, Jianhua Chen, Anne Segonds-Pichon, Susan E. Ozanne, Gavin Kelsey	42
13	The role of biomarkers in early diagnosis of chemotherapy-induced cardiotoxicity. 2010 ·(unknown), Elena Kinova, (unknown), (unknown), Stanimir Kyurkchiev, Ivan Kehayov, Elena V. Ivanova, (unknown), Assen Goudev	0
14	NMR solution structure and function of the C‐terminal domain of eukaryotic class 1 polypeptide chain release factor 2010 ·FEBS Journal ·Alexey B. Mantsyzov, Elena V. Ivanova, B. Birdsall, Elena Alkalaeva, (unknown), Geoff Kelly, Ludmila Frolova, Vladimir I. Polshakov	17
15	GOLPH3 modulates mTOR signalling and rapamycin sensitivity in cancer 2009 ·Nature ·Kenneth L. Scott, Omar Kabbarah, Mei‐Chih Liang, Elena V. Ivanova, Valsamo Anagnostou, Joyce C. Wu, Sabin Dhakal, Min Wu, Shujuan Chen, Tamar Y. Feinberg, Joseph Huang, Abdel Saci, Hans R. Widlund, David E. Fisher, Yonghong Xiao, David L. Rimm, Alexei Protopopov, Kwok‐Kin Wong, Lynda Chin	297
16	A Comparison of DNA Copy Number Profiling Platforms 2007 ·Cancer Research ·Joel Greshock, Bin Feng, Cristina Nogueira, Elena V. Ivanova, Ilana Perna, Katherine L. Nathanson, Alexei Protopopov, Barbara Weber, Lynda Chin	54
17	Common and Distinct Genomic Events in Sporadic Colorectal Cancer and Diverse Cancer Types 2007 ·Cancer Research ·Eric S. Martin, Giovanni Tonon, Raktim Sinha, Yonghong Xiao, Bin Feng, Alec C. Kimmelman, Alexei Protopopov, Elena V. Ivanova, Cameron Brennan, Kate Montgomery, Raju Kucherlapati, Gerald Bailey, Mark Redston, Lynda Chin, Ronald A. DePinho	54
18	The Differentiation and Stress Response Factor XBP-1 Drives Multiple Myeloma Pathogenesis 2007 ·Cancer Cell ·Daniel R. Carrasco, Kumar Sukhdeo, Marina Protopopova, Raktim Sinha, Miriam Enos, Daniel E. Carrasco, Mei Zheng, Mala Mani, Joel Henderson, Geraldine S. Pinkus, Nikhil C. Munshi, James W. Horner, Elena V. Ivanova, Alexei Protopopov, Kenneth C. Anderson, Giovanni Tonon, Ronald A. DePinho	311
19	HD CAG repeat implicates a dominant property of huntingtin in mitochondrial energy metabolism 2005 ·Human Molecular Genetics ·Ihn Sik Seong, Elena V. Ivanova, Jong‐Min Lee, (unknown), Elisa Fossale, (unknown), James F. Gusella, Jason M. Laramie, Richard H. Myers, Mathieu Lesort, Marcy E. MacDonald	235
20	Enhanced Akt Signaling Is an Early Pro-survival Response That Reflects N-Methyl-D-aspartate Receptor Activation in Huntington's Disease Knock-in Striatal Cells 2003 ·Journal of Biological Chemistry ·Sílvia Ginés, Elena V. Ivanova, (unknown), Carlos A. Saura, Marcy E. MacDonald	120

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact